Cervical Cancer

In a survey sent to women about midlife care, almost half of the respondents reported negative health care interactions. Only 18% reported positive or satisfying health care interactions.

Women with abnormal Pap or HPV test results who did not undergo colposcopy within 12 months had higher risk for subsequent cervical cancer compared with women who received colposcopy within that time frame, researchers reported.

The FDA announced several regulatory actions.

Tisotumab vedotin-tftv prolonged OS compared with chemotherapy alone among women with recurrent or metastatic cervical cancer, according to the agent’s manufacturers.

Women with disabilities, especially those with multiple and physical disabilities, had a lower likelihood of receiving the recommended cervical cancer screening using HPV testing, according to researchers.

New research has revealed that additional cervical cancer screenings may elevate the risk for preterm delivery among young women.

The rate of new cancer diagnoses among adults declined sharply in the early days of the COVID-19 pandemic, according to study results published in The Lancet Oncology.

Undergoing more cervical cancer screenings was associated with an increased risk for preterm birth among women aged 18 to 24 years, especially among those with hypertension or diabetes, researchers reported.

The addition of pembrolizumab to concurrent chemoradiotherapy conferred a statistically significant and clinically meaningful increase in PFS among women with newly diagnosed high-risk locally advanced cervical cancer, topline data showed.

So far in 2023, there has been an overwhelming shortage of chemotherapy drugs, of which several specifically impact gynecologic oncology providers and patients.